Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Impaired Liver Function”

431 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 431 results

Not applicableNot Yet RecruitingNCT06178302
What this trial is testing

DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP Practice

Who this might be right for
Liver DysfunctionThyroidAtherosclerosis+3 more
Imed19 1,000
Early research (Phase 1)Study completedNCT03562117
What this trial is testing

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 25
Early research (Phase 1)Study completedNCT07248839
What this trial is testing

Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Healthy VolunteersHepatic Impairment
Bristol-Myers Squibb 69
Early research (Phase 1)UnknownNCT05747664
What this trial is testing

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Diabetes Mellitus, Type 2
Daewoong Pharmaceutical Co. LTD. 24
Early research (Phase 1)Study completedNCT03890809
What this trial is testing

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

Who this might be right for
Liver DysfunctionHealthy Volunteers
Bristol-Myers Squibb 32
Very early researchUnknownNCT03673215
What this trial is testing

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

Who this might be right for
Liver Cirrhosis
Shenyang Sunshine Pharmaceutical Co., LTD. 58
Early research (Phase 1)Not Yet RecruitingNCT07457190
What this trial is testing

Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Generalized Anxiety Disorder
Beijing Union Pharmaceutical Factory Ltd 24
Not applicableUnknownNCT06129617
What this trial is testing

Intermittent ADVOS vs. Hemodialysis in Non-intensive Care Patients With Liver Dysfunction

Who this might be right for
Liver CirrhosisKidney Failure, AcuteKidney Replacement+1 more
University Medical Center Mainz 14
Early research (Phase 1)Study completedNCT01670734
What this trial is testing

Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 25
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Early research (Phase 1)Study completedNCT01012284
What this trial is testing

TMC207 in Patients With Moderately Impaired Hepatic Function

Who this might be right for
Moderate Hepatic Impairment
Tibotec BVBA 16
Early research (Phase 1)Study completedNCT00736905
What this trial is testing

TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

Who this might be right for
HIVAIDSHepatic Impairment
Tibotec Pharmaceuticals, Ireland 32
Early research (Phase 1)Study completedNCT06692322
What this trial is testing

Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 29
Early research (Phase 1)Study completedNCT02161770
What this trial is testing

Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Who this might be right for
Solid Tumours
AstraZeneca 30
Early research (Phase 1)Study completedNCT06908954
What this trial is testing

The Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Who this might be right for
Hepatic ImpairmentHealthy
Ipsen 31
Early research (Phase 1)Study completedNCT03627754
What this trial is testing

Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Who this might be right for
Hepatic Impairment
Pfizer 24
Early research (Phase 1)Study completedNCT00969813
What this trial is testing

A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Insufficiency
Pfizer 18
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Early research (Phase 1)Looking for participantsNCT07519135
What this trial is testing

Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function

Who this might be right for
Healthy
Pfizer 26
Early research (Phase 1)Study completedNCT05283915
What this trial is testing

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic Function Abnormal
Sanofi 10
Next Page